氟替美维吸入粉雾剂(Trelegy Ellipta)国内价格是多少

The domestic price of Flutimavir Inhalation Powder (TrelegyEllipta) may vary due to purchase channels, medical insurance reimbursement and other factors. You can consult relevant hospitals or pharmacies for specific prices.

What is the domestic price of Flutimavir Inhalation Powder Aerosol (Trelegy Ellipta)?

It has been launched in China and is included in medical insurance. The specific price will vary depending on the region, hospital, pharmacy and medical insurance policy, and it is impossible to obtain a specific price. Patients can check real-time prices through local hospital pharmacies, large chain pharmacies or official channels.

Factors affecting price

1. Drug ingredients and R&D costs

Flutimavir inhalation powder is a triple compound preparation, containing drug ingredients with three different mechanisms. The production process is complex and R&D investment is large. These factors directly push up the pricing of the drug.

2. Patent protection

During the patent protection period, drug prices are usually higher to ensure the company's R&D returns.

3. Policy and medical insurance negotiation

Flutimavir inhalation powder has been included in the national centralized procurement or passed medical insurance negotiation, and its price will be significantly reduced to benefit more patients.

The pictures are from public channels (such as the official website of the FDA, the official website of the original drug manufacturer, etc.) and are for reference only.

Indications of flutimavir inhalation powder spray (Trelegy Ellipta)

1. Chronic obstructive pulmonary disease (COPD)

Flutimavir inhalation powder spray is suitable for the maintenance treatment of chronic obstructive pulmonary disease, including chronic bronchitis and/or emphysema.

2. Asthma

This drug is also suitable for maintenance treatment of asthma patients aged 18 years and above, especially for those patients whose symptoms are still poor despite the use of other control drugs. It can effectively prevent asthma symptoms, improve lung function, and reduce acute attacks.

Drug interactions with flutemevir inhalation powder spray (Trelegy Ellipta)

1. Strong CYP3A4 inhibitors (such as ketoconazole)

Combined use with flutemevir inhalation powder spray (Trelegy Ellipta) may increase the systemic exposure of fluticasone and vilanterol, and should be used with caution.

2. Monoamine oxidase inhibitors, tricyclic antidepressants and QTc prolonging drugs

Combined use with flutimavir inhalation powder spray may enhance the effect of vilanterol on the cardiovascular system, so extreme caution is required.

3. Beta-adrenoceptor blockers

May cause bronchospasm and should be avoided. If necessary, use cardioselective beta-blockers.

4. Non-potassium sparing diuretics

Combined use may aggravate hypokalemia or electrocardiogram changes.

5. Anticholinergic drugs

Avoid combining with other anticholinergic drugs to prevent increased adverse reactions.